References
Lam MG, Banerjee A, Louie JD, Sze DY (2014) Splenomegaly-associated thrombocytopenia after hepatic yttrium-90 radioembolization. Cardiovasc Intervent Radiol 37(4):1009–1017
Tarantino G, Scalera A, Finelli C (2013) Liver-spleen axis: intersection between immunity, infections and metabolism. World J Gastroenterol 19(23):3534–3542
Asanoma M, Ikemoto T, Mori H, Utsunomiya T, Imura S, Morine Y et al (2013) Cytokine expression in spleen affects progression of liver cirrhosis through liver-spleen cross-talk. Hepatol Res. doi:10.1111/hepr.12267
Nosher JL, Ohman-Strickland PA, Jabbour S, Narra V, Nosher B (2011) Changes in liver and spleen volumes and liver function after radioembolization with yttrium-90 resin microspheres. J Vasc Interv Radiol 22(12):1706–1713
Paprottka PM, Schmidt GP, Trumm CG, Hoffmann RT, Reiser MF, Jakobs TF (2011) Changes in normal liver and spleen volume after radioembolization with (90)Y-resin microspheres in metastatic breast cancer patients: findings and clinical significance. Cardiovasc Intervent Radiol 34(5):964–972
Charters AC, Oakes DD, Froehlich JP (1980) Effect of hepatectomy on mitotic activity in the rat spleen. J Surg Res 29(4):331–337
Ueda S, Yamanoi A, Hishikawa Y, Dhar DK, Tachibana M, Nagasue N (2003) Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats. Lab Invest 83(11):1595–1603
Akahoshi T, Hashizume M, Tanoue K, Shimabukuro R, Gotoh N, Tomikawa M et al (2002) Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol 17(1):59–65
Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V et al (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274(5291):1379–1383
Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A et al (2009) Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 21(5):504–511
Watanabe M, Murata S, Hashimoto I, Nakano Y, Ikeda O, Aoyagi Y et al (2009) Platelets contribute to the reduction of liver fibrosis in mice. J Gastroenterol Hepatol 24(1):78–89
Sugawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Takayama T et al (2000) J Splenectomy in patients with hepatocellular carcinoma and hypersplenism. Am Coll Surg 190(4):446–450
Chen XP, Wu ZD, Huang ZY, Qiu FZ (2005) Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg 92:334–339
Kuriyama N, Isaji S, Kishiwada M, Ohsawa I, Hamada T, Mizuno S et al (2012) Dual cytoprotective effects of splenectomy for small-for-size liver transplantation in rats. Liver Transpl 18(11):1361–1370
Kim SJ, Na GH, Choi HJ, You Y, Kim DG (2013) Effect of donor right hepatectomy on splenic volume and platelet count for living donor liver transplantation. J Gastrointest Surg 17(9):1576–1583
Ozban M, Genc V, Karaca S, Cetinkaya OA, Oztuna D (2012) The effects of exercise on portal venous system in splenectomized adults. Bratisl Lek Listy 113(6):376–378
Akan AA, Sengül N, Simşek S, Demirer S (2008) The effects of splenectomy and splenic autotransplantation on plasma lipid levels. J Invest Surg 21(6):369–372
Alberti LR, Veloso DF, Vasconcellos Lde S, Petroianu A (2012) Is there a relationship between lipids metabolism and splenic surgeries? Acta Cir Bras 27(11):751–756
Wang B, Li B, Dai Z, Ren S, Bai M, Wang Z et al (2014) Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4 + CD25 + Treg cells. Int J Biochem Cell Biol 55C:98–108
Conflict of interest
Mehran Midia has no conflict of interest.
Statement of Human and Animal Rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Statement of Informed Consent
Informed consent was not required for this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Midia, M. Spleen: Promised Land for New and Novel Interventions?. Cardiovasc Intervent Radiol 38, 501–502 (2015). https://doi.org/10.1007/s00270-014-1029-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-014-1029-4